Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure (Q34448251)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure
scientific article

    Statements

    Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure (English)
    0 references
    0 references
    Akshay S Desai
    Jianjian Gong
    Martin P Lefkowitz
    Scott D Solomon
    Karl Andersen
    Juan Luis Arango
    J Malcolm Arnold
    Jan Bělohlávek
    Michael Böhm
    Lesley J Burgess
    Walter Cabrera
    Carlos Calvo
    Chen-Huan Chen
    Andrej Dukat
    Yan Carlos Duarte
    Andrejs Erglis
    Michael Fu
    Efrain Gomez
    Angel Gonzàlez-Medina
    Albert A Hagège
    Tzvetana Katova
    Songsak Kiatchoosakun
    Kee-Sik Kim
    Edmundo Bayram Llamas
    Felipe Martinez
    Bela Merkely
    Iván Mendoza
    Keijo Peuhkurinen
    Jens Refsgaard
    Arvo Rosenthal
    Antonio S Sibulo
    José Silva-Cardoso
    Dragos Vinereanu
    Raymond Ching-Chiew Wong
    PARADIGM-HF Investigators and Coordinators
    17 November 2014

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit